IDXX vs. CLS
IDXX (IDEXX Laboratories, Inc.) and CLS (Celestica Inc.) are both stocks. IDXX operates in Diagnostics & Research (Healthcare), while CLS operates in Electronic Components (Technology). Over the past 10 years, IDXX returned 20.23%/yr vs 43.16%/yr for CLS. At a 0.28 correlation, their price movements are largely independent.
Performance
IDXX vs. CLS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDXX achieves a -17.05% return, which is significantly lower than CLS's 30.75% return. Over the past 10 years, IDXX has underperformed CLS with an annualized return of 20.23%, while CLS has yielded a comparatively higher 43.16% annualized return.
IDXX
- 1D
- -0.18%
- 1M
- 0.19%
- YTD
- -17.05%
- 6M
- -20.59%
- 1Y
- 6.91%
- 3Y*
- 7.57%
- 5Y*
- -0.19%
- 10Y*
- 20.23%
CLS
- 1D
- 3.98%
- 1M
- 2.92%
- YTD
- 30.75%
- 6M
- 13.42%
- 1Y
- 220.14%
- 3Y*
- 209.55%
- 5Y*
- 114.81%
- 10Y*
- 43.16%
IDXX vs. CLS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IDXX IDEXX Laboratories, Inc. | -17.05% | 63.63% | -25.51% | 36.06% | -38.04% | 31.73% | 91.43% | 40.38% | 18.95% | 33.35% |
CLS Celestica Inc. | 30.75% | 220.27% | 215.23% | 159.80% | 1.26% | 37.92% | -2.42% | -5.70% | -16.32% | -11.56% |
Correlation
The correlation between IDXX and CLS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 1998 | 0.28 |
Fundamentals
IDXX:
$18.08
CLS:
$8.28
IDXX:
31.04
CLS:
46.65
IDXX:
2.68
CLS:
0.63
IDXX:
7.65
CLS:
3.24
IDXX:
$4.45B
CLS:
$13.81B
IDXX:
$2.76B
CLS:
$1.60B
IDXX:
$1.52B
CLS:
$1.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDXX vs. CLS — Risk / Return Rank
IDXX
CLS
IDXX vs. CLS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDXX | CLS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.89 | ||
| Sortino ratioReturn per unit of downside risk | -2.24 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.39 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | 7.58 | -7.36 |
| Martin ratioReturn relative to average drawdown | 0.46 | 18.88 | -18.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDXX | CLS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.17 | 3.06 | -2.89 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.01 | 2.01 | -2.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.87 | -0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.27 | +0.24 |
Drawdowns
IDXX vs. CLS - Drawdown Comparison
The maximum IDXX drawdown since its inception was -81.42%, smaller than the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for IDXX and CLS.
Loading charts...
Drawdown Indicators
| IDXX | CLS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.42% | -96.93% | +15.51% |
Max Drawdown (1Y)Largest decline over 1 year | -31.04% | -29.24% | -1.80% |
Max Drawdown (3Y)Largest decline over 3 years | -37.41% | -53.96% | +16.55% |
Max Drawdown (5Y)Largest decline over 5 years | -54.00% | -53.96% | -0.04% |
Max Drawdown (10Y)Largest decline over 10 years | -54.00% | -80.60% | +26.60% |
Current DrawdownCurrent decline from peak | -26.81% | -18.18% | -8.63% |
Average DrawdownAverage peak-to-trough decline | -21.00% | -73.36% | +52.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.03% | 11.72% | +3.31% |
Volatility
IDXX vs. CLS - Volatility Comparison
The current volatility for IDEXX Laboratories, Inc. (IDXX) is 8.57%, while Celestica Inc. (CLS) has a volatility of 26.60%. This indicates that IDXX experiences smaller price fluctuations and is considered to be less risky than CLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDXX | CLS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.57% | 26.60% | -18.03% |
Volatility (6M)Calculated over the trailing 6-month period | 19.89% | 55.08% | -35.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.46% | 72.52% | -31.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.28% | 57.62% | -22.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.01% | 49.93% | -16.92% |
Dividends
IDXX vs. CLS - Dividend Comparison
Neither IDXX nor CLS has paid dividends to shareholders.
Financials
IDXX vs. CLS - Financials Comparison
This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IDXX vs. CLS - Profitability Comparison
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
CLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
CLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 272.10M and revenue of 4.05B, resulting in an operating margin of 6.7%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
CLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
IDXX and CLS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLS has higher volatility (26.60%) compared to IDXX (8.57%). In terms of maximum drawdown, IDXX dropped -81.42% vs CLS's -96.93%.
CLS currently has the higher Sharpe Ratio (3.06 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDXX and CLS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer